Targeting occult tumor cell dissemination in localized breast cancer
- Prosjektnummer
- 2011039
- Ansvarlig person
- Bjørn Naume
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Ekstraordinære driftsmidler
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling.
Proc Natl Acad Sci U S A 2012 Feb;109(8):2802-7. Epub 2011 sep 9
PMID: 21908711
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
Int J Cancer 2012 Aug;131(4):E405-15. Epub 2011 nov 9
PMID: 21935921
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients.
PLoS One 2012;7(2):e32426. Epub 2012 feb 23
PMID: 22384245
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Histopathology 2012 Sep;61(3):350-64. Epub 2012 jun 13
PMID: 22690749
The landscape of cancer genes and mutational processes in breast cancer.
Nature 2012 Jun;486(7403):400-4. Epub 2012 mai 16
PMID: 22722201
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Breast Cancer Res 2012 Aug;14(4):R117. Epub 2012 aug 14
PMID: 22889108
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.
Histol Histopathol 2012 Oct;27(10):1315-25.
PMID: 22936450
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.
BMC Cancer 2012 Dec;12(1):616. Epub 2012 des 22
PMID: 23259667
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.
Mol Oncol 2011 Feb;5(1):77-92. Epub 2010 des 2
PMID: 21169070
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.
Mol Oncol 2011 Feb;5(1):61-76. Epub 2010 nov 25
PMID: 21212030
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors.
PLoS One 2011;6(2):e16915. Epub 2011 feb 22
PMID: 21364938
Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.
Clin Cancer Res 2011 May;17(9):2967-76. Epub 2011 mar 17
PMID: 21415211
Combining gene signatures improves prediction of breast cancer survival.
PLoS One 2011;6(3):e17845. Epub 2011 mar 10
PMID: 21423775
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
Breast Cancer Res 2011;13(3):R61. Epub 2011 jun 14
PMID: 21672237
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer.
Oral Presentasjon. ACTC meeting Athens 26.-29. september 2012
Disseminated tumor cells in breast cancer
Invited Speaker. ACTC meeting Athens 26.-29. september 2012
Prognostic impact of disseminated and circulating tumor cells in patients treated for locally advanced breast cancer
Poster presentation. ACTC meeting Athens 26.-29. september 2012
Disseminated tumour cells in the bone marrow in early breast cancer – morphological categories of immunocytochemically positive
Oral Presentasjon. ACTC meeting Athens 26.-29. september 2012
The prognostic significance of tumor cell detection in peripheral blood versus bone marrow in early breast cancer.
Oral Presentation. 8th International Symposium on Minimal Residual Disease. Osaka. Japan 21.-23. sseptember 2011.
Morphological categories of ICC-detected CK+ cells in bone marrow have different prognostic impact in breast cancer
Poster presentation. 8th International Symposium on Minimal Residual Disease. Osaka. Japan 21.-23. sseptember 2011.
High resolution analyses of copy number changes in circulating and disseminated tumor cells of patients with breast cancer.
Oral Presentation. 8th International Symposium on Minimal Residual Disease. Osaka. Japan 21.-23. sseptember 2011.
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from breast
Poster presentation. 8th International Symposium on Minimal Residual Disease. Osaka. Japan 21.-23. sseptember 2011.
DTC detection by multi-marker QPCR in early breast cancer. Methodolocical aspects
Poster presentation. 8th International Symposium on Minimal Residual Disease. Osaka. Japan 21.-23. sseptember 2011.
Prognostic impact of disseminated and circulating tumor cells in patients treated for locally advanced breast cancer
Poster presentation. SABCS 2011. Cancer Research, Volume 71: 444s, P4-06-05
Presence of DTC after adjuvant chemotherapy in breast cancer and DTC monitoring during secondary adjuvant treatment.
Poster presentation. SABCS 2011. Cancer Research, Volume 71: 581s, P5-18-07
Morphological categories of ICC-detected CK+ cells in bone marrow have different prognostic impact in breast cancer
Poster presentation. SABCS 2011. Cancer Research, Volume 71: 444s, P4-06-06
Systems Biology and Genomics of Breast Cancer through mining multi-level molecular profiles
- Disputert:
- desember 2011
- Hovedveileder:
- Anne-Lise Børresen-Dale
Angiogenesis in invasive breast carcinomas: a clinicopathological study
- Disputert:
- november 2011
- Hovedveileder:
- Jahn M. Nesland
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport